Perspective Therapeutics Inc (CATX)

개요 뉴스 가격 이력 토론 예측 주식 분할

Relative Volume:

Perspective Therapeutics Inc Stock (CATX) Company Profile

Perspective Therapeutics Inc

Healthcare (1161)

Medical Devices (147)

509-375-1202

350 Hills Street, Suite 106, Richland

최신 SEC 제출 서류

CATX's Discussions on Twitter

CATX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
CATX Perspective Therapeutics Inc	4.395	296.91M	6.96M	-46.51M	-37.99M	-0.1716
ABT Abbott Laboratories	124.69	229.71B	43.11B	13.98B	6.66B	7.98
BSX Boston Scientific Corp	103.86	154.35B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	392.82	149.60B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	90.68	114.97B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.84	45.92B	5.54B	4.18B	623.10M	7.00

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-03-13	개시	H.C. Wainwright	Buy
2025-03-07	개시	Scotiabank	Sector Outperform
2024-11-25	다운그레이드	BofA Securities	Buy → Neutral
2024-10-24	개시	UBS	Buy
2024-10-01	개시	Wedbush	Outperform
2024-09-25	개시	Truist	Buy
2024-07-25	개시	BofA Securities	Buy
2024-05-09	개시	Cantor Fitzgerald	Overweight

Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스

Perspective Therapeutics Inc (CATX) 재무 분석

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc Stock (CATX) Company Profile

CATX을(를) 다른 주식과 비교

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스

Perspective Therapeutics Inc. Stock Analysis and ForecastExtraordinary performance - Autocar Professional

What drives Perspective Therapeutics Inc. stock priceTriple-digit wealth increases - Autocar Professional

Is Perspective Therapeutics Inc. a good long term investmentSkyrocketing returns - Autocar Professional

What analysts say about Perspective Therapeutics Inc. stockUnprecedented profit potential - jammulinksnews.com

Why Perspective Therapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser

How Perspective Therapeutics Inc. stock performs during market volatilityIntraday Trade Ideas - Newser

What makes Perspective Therapeutics Inc. stock price move sharplyHigh Return Setup Scanner - Newser

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial Results - The Manila Times

Cancer Treatment Pioneer Perspective Therapeutics Announces Q2 2025 Earnings Date: Key Updates Coming - Stock Titan

Top Reasons to Buy SBT(sbtcoin)Free Stock Market Practical Discussion Forums - newser.com

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Perspective Therapeutics Inc (CATX Stock: A Sea of Opportunity - investchronicle.com

Perspective Therapeutics Updates Strategic Focus on Radiopharmaceuticals - TipRanks

Perspective Therapeutics, Inc.(NYSEAM: CATX) dropped from Russell 3000 Growth Index - MarketScreener

Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Vertex Pharmaceuticals (VRTX) and Edgewise Therapeutics (EWTX) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail

Perspective Therapeutics (CATX) Maintains 'Outperform' Rating by Wedbush | CATX Stock News - GuruFocus

Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial - Yahoo Finance

Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - Finansavisen

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Rating of “Buy” from Analysts - Defense World

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Bank of America Corp DE - Defense World

Analyzing Ratios: Perspective Therapeutics Inc (CATX)’s Financial Story Unveiled - DWinneX

New Research Reveals Top 6 Radioligand Therapy Companies Transforming Cancer Treatment in $13B Market - Stock Titan

The Goldilocks Isotope: Perspective Therapeutics’ ‘Just Right’ Alpha Radiotherapeutic - insights.citeline.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Warren Buffett Says Buy This Index Fund, and Here's How It Could Turn $500 Per Month Into $1 Million - The Globe and Mail

Cantor Fitzgerald Forecasts CATX FY2026 Earnings - Defense World

Ameriprise Financial Inc. Sells 645,170 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Stocks Sharply Higher on a Better-Than-Expected US May Payroll Report - The Globe and Mail

151,610 Shares in Perspective Therapeutics, Inc. (NYSE:CATX) Acquired by Two Sigma Advisers LP - Defense World

ProShare Advisors LLC Acquires 5,011 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Perspective Therapeutics (NYSE:CATX) Rating Increased to Moderate Buy at Royal Bank of Canada - Defense World

3 Promising Penny Stocks With Market Caps Over $90M - simplywall.st

Perspective Therapeutics (CATX) Price Target Raised by RBC Capital | CATX Stock News - GuruFocus

Perspective Therapeutics (CATX) Gets a Buy from Scotiabank - The Globe and Mail

RBC Capital Boosts Price Target for Perspective Therapeutics (CA - GuruFocus

Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks

RBC Capital raises Perspective Therapeutics stock price target to $16 By Investing.com - Investing.com Nigeria

RBC Raises Price Target on Perspective Therapeutics to $16 From $15, Keeps Outperform, Speculative Risk - marketscreener.com

RBC Capital raises Perspective Therapeutics stock price target to $16 - Investing.com

Perspective Therapeutics Inc (CATX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

CATX과 유사한 종목